| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
338,137 |
237,957 |
$13.36M |
| 94760 |
|
219,438 |
111,683 |
$5.99M |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
116,281 |
83,252 |
$2.48M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
53,902 |
34,442 |
$2.25M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
33,172 |
24,536 |
$1.57M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
43,280 |
23,030 |
$1.53M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
22,435 |
12,355 |
$993K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
28,187 |
17,854 |
$922K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
22,126 |
12,814 |
$872K |
| 17110 |
|
8,153 |
6,999 |
$842K |
| G0511 |
Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month |
8,337 |
4,264 |
$672K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
16,613 |
10,810 |
$524K |
| 36415 |
Collection of venous blood by venipuncture |
39,056 |
27,770 |
$367K |
| 99401 |
|
11,198 |
4,845 |
$331K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
10,431 |
10,287 |
$259K |
| D1110 |
Prophylaxis - adult |
5,558 |
5,558 |
$205K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
5,552 |
3,379 |
$193K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
9,101 |
7,748 |
$188K |
| D0120 |
Periodic oral evaluation - established patient |
8,296 |
8,296 |
$179K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
28,327 |
16,683 |
$173K |
| 99173 |
|
7,760 |
3,706 |
$161K |
| D0220 |
Intraoral - periapical first radiographic image |
14,894 |
14,812 |
$152K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
19,542 |
19,000 |
$151K |
| 99381 |
|
1,721 |
1,151 |
$140K |
| 85018 |
|
14,711 |
11,710 |
$138K |
| 81000 |
|
8,597 |
5,977 |
$132K |
| 99490 |
Ccm add 20min |
1,563 |
825 |
$128K |
| D0140 |
Limited oral evaluation - problem focused |
10,684 |
10,285 |
$111K |
| D2392 |
Resin-based composite - two surfaces, posterior, primary or permanent |
2,017 |
1,528 |
$101K |
| D1120 |
Prophylaxis - child |
3,013 |
3,013 |
$98K |
| 83655 |
|
5,072 |
3,475 |
$96K |
| 11730 |
|
1,713 |
732 |
$95K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
3,561 |
1,493 |
$95K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,765 |
1,653 |
$85K |
| D0274 |
Bitewings - four radiographic images |
4,314 |
4,314 |
$84K |
| 11721 |
|
1,809 |
1,104 |
$77K |
| 36416 |
|
5,404 |
3,558 |
$76K |
| 99215 |
Prolong outpt/office vis |
2,034 |
904 |
$73K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
955 |
695 |
$72K |
| D2751 |
Crown - porcelain fused to predominantly base metal |
194 |
187 |
$70K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,339 |
1,140 |
$68K |
| D0270 |
|
5,996 |
5,965 |
$63K |
| D0272 |
Bitewings - two radiographic images |
3,802 |
3,799 |
$48K |
| 69210 |
|
2,030 |
1,566 |
$48K |
| 10060 |
|
691 |
593 |
$44K |
| 11720 |
|
883 |
547 |
$37K |
| 92551 |
|
3,388 |
2,968 |
$33K |
| D2930 |
Prefabricated stainless steel crown - primary tooth |
458 |
334 |
$32K |
| D1208 |
Topical application of fluoride, excluding varnish |
2,866 |
2,866 |
$32K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
100 |
100 |
$29K |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
840 |
684 |
$28K |
| 90723 |
|
2,521 |
1,796 |
$26K |
| D2150 |
Silver amalgam - two surfaces, primary or permanent |
555 |
475 |
$26K |
| 71046 |
Radiologic examination, chest; 2 views |
4,197 |
3,906 |
$25K |
| 17111 |
|
188 |
173 |
$24K |
| D3220 |
Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction |
432 |
314 |
$23K |
| 0012A |
|
721 |
721 |
$22K |
| D1206 |
Topical application of fluoride varnish |
779 |
779 |
$20K |
| 93000 |
|
1,085 |
858 |
$19K |
| D3320 |
|
106 |
102 |
$17K |
| 0011A |
|
720 |
719 |
$17K |
| D0230 |
Intraoral - periapical each additional radiographic image |
3,231 |
3,230 |
$16K |
| D1351 |
Sealant - per tooth |
420 |
187 |
$15K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
2,863 |
1,529 |
$14K |
| 90686 |
|
2,660 |
2,648 |
$12K |
| 90461 |
|
7,617 |
7,519 |
$11K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
419 |
265 |
$10K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,043 |
902 |
$10K |
| 90677 |
|
704 |
704 |
$9K |
| D9110 |
|
507 |
499 |
$8K |
| D0150 |
Comprehensive oral evaluation - new or established patient |
372 |
372 |
$8K |
| D7140 |
Extraction, erupted tooth or exposed root |
214 |
183 |
$7K |
| 12001 |
|
83 |
83 |
$6K |
| 0064A |
|
141 |
141 |
$5K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
90 |
37 |
$5K |
| 11900 |
|
95 |
88 |
$5K |
| 0001A |
|
124 |
124 |
$5K |
| D2140 |
|
157 |
129 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
101 |
95 |
$4K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
12 |
12 |
$3K |
| D2393 |
Resin-based composite - three surfaces, posterior, primary or permanent |
50 |
46 |
$3K |
| 0071A |
|
75 |
75 |
$3K |
| 99441 |
|
94 |
83 |
$3K |
| 11102 |
|
25 |
25 |
$2K |
| 0072A |
|
66 |
66 |
$2K |
| 0002A |
|
59 |
59 |
$2K |
| D2954 |
|
25 |
24 |
$2K |
| D0210 |
Intraoral - complete series of radiographic images |
245 |
243 |
$2K |
| 90670 |
|
1,290 |
1,240 |
$2K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
34 |
15 |
$2K |
| 90648 |
|
728 |
685 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
171 |
160 |
$1K |
| G0466 |
Federally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
116 |
32 |
$1K |
| 73630 |
|
148 |
139 |
$1K |
| 90710 |
|
500 |
481 |
$1K |
| 99443 |
|
28 |
27 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
486 |
460 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
21 |
13 |
$1K |
| 90716 |
|
285 |
266 |
$975.66 |
| 90682 |
|
16 |
16 |
$900.00 |
| 99000 |
|
2,955 |
2,896 |
$850.88 |
| 0031A |
|
24 |
24 |
$694.84 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
329 |
311 |
$679.76 |
| 90715 |
|
218 |
209 |
$616.33 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
50 |
36 |
$572.56 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
48 |
42 |
$569.22 |
| 90734 |
|
54 |
40 |
$549.36 |
| 73140 |
|
29 |
25 |
$454.08 |
| D1354 |
|
27 |
17 |
$450.00 |
| 86580 |
|
26 |
22 |
$403.04 |
| 90656 |
|
100 |
100 |
$150.06 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
100 |
60 |
$140.09 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
28 |
16 |
$122.83 |
| 81025 |
|
65 |
65 |
$40.98 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
122 |
119 |
$24.47 |
| 85048 |
|
32 |
29 |
$1.14 |
| 91307 |
|
121 |
115 |
$0.41 |
| 91306 |
|
119 |
119 |
$0.39 |
| 91300 |
|
198 |
186 |
$0.25 |
| 91301 |
|
923 |
906 |
$0.12 |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
19 |
19 |
$0.11 |
| 91303 |
|
43 |
43 |
$0.01 |
| 90619 |
|
297 |
297 |
$0.00 |
| 90697 |
|
394 |
394 |
$0.00 |
| 90696 |
|
314 |
314 |
$0.00 |
| 90651 |
|
15 |
15 |
$0.00 |
| 90660 |
|
13 |
13 |
$0.00 |
| 90707 |
|
242 |
242 |
$0.00 |
| 73130 |
|
17 |
17 |
$0.00 |
| 90700 |
|
181 |
181 |
$0.00 |
| Q0239 |
Injection, bamlanivimab-xxxx, 700 mg |
19 |
19 |
$0.00 |
| 90672 |
|
71 |
71 |
$0.00 |
| 90661 |
|
20 |
20 |
$0.00 |